Sorry: just an update today . . .
Guru writes of yesterday’s FDA panel: “The important vote on ETRM was 6 yes, 2 no, 1 abstain that benefit outweighs risk. That’s what we wanted. On safety, the vote was 8 yes, 1 no. On efficacy, however, the vote was 4 yes, 5 no. Yet the vote earlier in the day on whether the 18 month data supported efficacy was 9 yes 0 no. Doctors who earlier in the day had voted ‘yes’ that the 12- and 18-month data showed efficacy voted ‘no’ on the official ‘efficacy’ vote. Go figure. The FDA will approve their device in my opinion.”
Those of us who bought shares with money we truly can afford to lose await the decision — and the market’s reaction — with nervous anticipation.
Quote of the Day
A good listener is not only popular everywhere, but after a while he knows something.~Wilson Mizner
Request email delivery
- Aug 22:
Do You Make More Than $5 Million A Year?
- Aug 21:
A Well-Regulated Militia
- Aug 20:
Amazing iPhone Tip: You Have A Free Scanner!
- Aug 18:
400 Years Later
- Aug 16:
$5,000 For A New Knee; $400,000 For Literally Nothing
- Aug 15:
Bush 43’s Chief Speechwriter On Trump
- Aug 14:
Need A New Hip? A New Heart? Some Tomatoes?
- Aug 13:
Loving My Burgers
- Aug 12:
- Aug 10:
- Aug 22: